APPLICATION OF INHIBITOR ANALYSIS FOR STUDYING MECHANISMS AND ACTIONS OF POLYMURAMYL, A MURAMYL PEPTIDE-BASED IMMUNE MODULATOR

In present study, the following low-MW inhibitors were used to dissect mechanisms of action for two muramyl peptide components of Polymuramyl, an immunomodulatory drug: (1) N-acetyl-D-glucosaminyl-(β1→4)-N-acetyl-D-muramoyl-L-alanyl-D-isoglutaminyl-meso-diaminopimelic acid (GMtri); (2) a dimeric   m...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: M. V. Pashenkov, B. I. Alkhazova, V. L. L'vov, B. V. Pinegin
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2014
Materias:
Acceso en línea:https://doaj.org/article/db6b35ba9c5048e3a0daf4c792ec858c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:db6b35ba9c5048e3a0daf4c792ec858c
record_format dspace
spelling oai:doaj.org-article:db6b35ba9c5048e3a0daf4c792ec858c2021-11-18T08:03:37ZAPPLICATION OF INHIBITOR ANALYSIS FOR STUDYING MECHANISMS AND ACTIONS OF POLYMURAMYL, A MURAMYL PEPTIDE-BASED IMMUNE MODULATOR1563-06252313-741X10.15789/1563-0625-2013-1-21-28https://doaj.org/article/db6b35ba9c5048e3a0daf4c792ec858c2014-07-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/59https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XIn present study, the following low-MW inhibitors were used to dissect mechanisms of action for two muramyl peptide components of Polymuramyl, an immunomodulatory drug: (1) N-acetyl-D-glucosaminyl-(β1→4)-N-acetyl-D-muramoyl-L-alanyl-D-isoglutaminyl-meso-diaminopimelic acid (GMtri); (2) a dimeric   muramyl peptide (diGMtetra), wherein two monomers [N-acetyl-D-glucosaminyl-(β1→4)-N-acetyl-D-muramoyl-L-alanyl-D-isoglutaminyl-meso-diaminopimeloyl-D-alanin] are linked via an amide bond between the carboxyl group of terminal D-alanin at one monomer and the ω-amino group of meso-diaminopimelic acid at another monomer. In vitro production of tumor necrosis factor (TNF) by human macrophages stimulated with GMtri or diGMtetra was shown to be inhibited by SB203580 (a RIP2 kinase inhibitor), genistein (a protein tyrosine kinase inhibitor) and BAY 11-7082 (an IκB-kinase inhibitor). Moreover, response to diGMtetra was inhibited by dynasore (an inhibitor of clathrin-dependent endocytosis), as well as by a broad-range protease-inhibiting cocktail. Thus, activating effects upon macrophages induced by the Polymuramyl components is provided by, at least, three biological processes: (1) clathrin-dependent endocytosis; (2) peptidase-mediated processing of diGMtetra; 3) activation of a signal chain RIP2 – IκB-kinase – NF-κB transcription factor.M. V. PashenkovB. I. AlkhazovaV. L. L'vovB. V. PineginSPb RAACIarticlemuramyl peptidesmacrophagessb203580genisteintumor necrosis factorImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 15, Iss 1, Pp 21-28 (2014)
institution DOAJ
collection DOAJ
language RU
topic muramyl peptides
macrophages
sb203580
genistein
tumor necrosis factor
Immunologic diseases. Allergy
RC581-607
spellingShingle muramyl peptides
macrophages
sb203580
genistein
tumor necrosis factor
Immunologic diseases. Allergy
RC581-607
M. V. Pashenkov
B. I. Alkhazova
V. L. L'vov
B. V. Pinegin
APPLICATION OF INHIBITOR ANALYSIS FOR STUDYING MECHANISMS AND ACTIONS OF POLYMURAMYL, A MURAMYL PEPTIDE-BASED IMMUNE MODULATOR
description In present study, the following low-MW inhibitors were used to dissect mechanisms of action for two muramyl peptide components of Polymuramyl, an immunomodulatory drug: (1) N-acetyl-D-glucosaminyl-(β1→4)-N-acetyl-D-muramoyl-L-alanyl-D-isoglutaminyl-meso-diaminopimelic acid (GMtri); (2) a dimeric   muramyl peptide (diGMtetra), wherein two monomers [N-acetyl-D-glucosaminyl-(β1→4)-N-acetyl-D-muramoyl-L-alanyl-D-isoglutaminyl-meso-diaminopimeloyl-D-alanin] are linked via an amide bond between the carboxyl group of terminal D-alanin at one monomer and the ω-amino group of meso-diaminopimelic acid at another monomer. In vitro production of tumor necrosis factor (TNF) by human macrophages stimulated with GMtri or diGMtetra was shown to be inhibited by SB203580 (a RIP2 kinase inhibitor), genistein (a protein tyrosine kinase inhibitor) and BAY 11-7082 (an IκB-kinase inhibitor). Moreover, response to diGMtetra was inhibited by dynasore (an inhibitor of clathrin-dependent endocytosis), as well as by a broad-range protease-inhibiting cocktail. Thus, activating effects upon macrophages induced by the Polymuramyl components is provided by, at least, three biological processes: (1) clathrin-dependent endocytosis; (2) peptidase-mediated processing of diGMtetra; 3) activation of a signal chain RIP2 – IκB-kinase – NF-κB transcription factor.
format article
author M. V. Pashenkov
B. I. Alkhazova
V. L. L'vov
B. V. Pinegin
author_facet M. V. Pashenkov
B. I. Alkhazova
V. L. L'vov
B. V. Pinegin
author_sort M. V. Pashenkov
title APPLICATION OF INHIBITOR ANALYSIS FOR STUDYING MECHANISMS AND ACTIONS OF POLYMURAMYL, A MURAMYL PEPTIDE-BASED IMMUNE MODULATOR
title_short APPLICATION OF INHIBITOR ANALYSIS FOR STUDYING MECHANISMS AND ACTIONS OF POLYMURAMYL, A MURAMYL PEPTIDE-BASED IMMUNE MODULATOR
title_full APPLICATION OF INHIBITOR ANALYSIS FOR STUDYING MECHANISMS AND ACTIONS OF POLYMURAMYL, A MURAMYL PEPTIDE-BASED IMMUNE MODULATOR
title_fullStr APPLICATION OF INHIBITOR ANALYSIS FOR STUDYING MECHANISMS AND ACTIONS OF POLYMURAMYL, A MURAMYL PEPTIDE-BASED IMMUNE MODULATOR
title_full_unstemmed APPLICATION OF INHIBITOR ANALYSIS FOR STUDYING MECHANISMS AND ACTIONS OF POLYMURAMYL, A MURAMYL PEPTIDE-BASED IMMUNE MODULATOR
title_sort application of inhibitor analysis for studying mechanisms and actions of polymuramyl, a muramyl peptide-based immune modulator
publisher SPb RAACI
publishDate 2014
url https://doaj.org/article/db6b35ba9c5048e3a0daf4c792ec858c
work_keys_str_mv AT mvpashenkov applicationofinhibitoranalysisforstudyingmechanismsandactionsofpolymuramylamuramylpeptidebasedimmunemodulator
AT bialkhazova applicationofinhibitoranalysisforstudyingmechanismsandactionsofpolymuramylamuramylpeptidebasedimmunemodulator
AT vllvov applicationofinhibitoranalysisforstudyingmechanismsandactionsofpolymuramylamuramylpeptidebasedimmunemodulator
AT bvpinegin applicationofinhibitoranalysisforstudyingmechanismsandactionsofpolymuramylamuramylpeptidebasedimmunemodulator
_version_ 1718422573417496576